Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View Plans2-year trend showing gross, operating, and net profit margins
Amrutanjan Health Care Limited's net profit margin of 10.8% in FY2025 reflects moderate profitability, with operating margin at 14.8% and gross margin at 52.5%.
In FY 2025, Amrutanjan Health Care Limited posted a gross margin of 52.5%, an operating margin of 14.8%, a net margin of 10.8%. Gross Margin = (Revenue - COGS) / Revenue; Operating Margin = EBIT / Revenue; Net Margin = Net Income / Revenue. Typical healthy ranges: Gross 20-40%, Operating 10-20%, Net 5-10%+. Consistent or improving margins indicate strong competitive positioning.
2-year trend showing revenue, gross profit, and net profit
Amrutanjan Health Care Limited's revenue grew 7.1% to 4.69B and net profit grew 13.0% to 508.35M YoY in FY2025, indicating moderate business momentum.
In FY 2025, Amrutanjan Health Care Limited's revenue grew by 7.1% year-over-year. Revenue is total income from operations. Gross Profit is revenue minus cost of goods. Net Profit is the bottom line after all expenses. Consistent growth across all three signals a healthy, expanding business.
2-year trend showing shareholder returns
Amrutanjan Health Care Limited's ROE of 15.6% in FY2025 indicates good shareholder returns.
In FY 2025, Amrutanjan Health Care Limited reported an ROE of 15.6%. ROE = (Net Income / Shareholders' Equity) x 100. Measures how efficiently the company turns equity into profit. Above 15% is generally strong; above 25% is excellent. Very high ROE may signal high leverage — check alongside debt levels.
2-year trend comparing profitability with cash generation
Amrutanjan Health Care Limited's FCF/NI ratio of 0.30x in FY2025 indicates weak cash generation raising concerns about earnings quality.
In FY 2025, Amrutanjan Health Care Limited's free cash flow trailed net income. Free Cash Flow = Operating Cash Flow - Capital Expenditure. When FCF exceeds net income, it suggests high-quality, cash-backed earnings. Persistent gaps may indicate aggressive accounting or heavy capex needs.
2-year trend comparing profitability with cash from operations
Amrutanjan Health Care Limited's OCF/NI ratio of 1.00x in FY2025 indicates sound cash management with earnings well-backed by cash.
In FY 2025, Amrutanjan Health Care Limited's operating cash flow exceeded net income. Operating Cash Flow is the actual cash from core operations. OCF exceeding net income signals strong cash collection. OCF trailing net income may indicate aggressive revenue recognition or working capital issues.
Measure a company's financial leverage, liquidity, and ability to meet financial obligations.
2-year trend showing short-term liquidity position
Amrutanjan Health Care Limited's current ratio of 3.44x in FY2025 indicates ample liquidity, though assets may be underutilized.
In FY 2025, Amrutanjan Health Care Limited reported a current ratio of 3.44. Current Ratio = Current Assets / Current Liabilities. Measures short-term liquidity. A ratio of 1.5-3.0 is generally healthy; below 1.0 signals liquidity risk; above 3.0 may indicate underutilized assets.
2-year trend showing ability to service debt
Amrutanjan Health Care Limited's interest coverage ratio of 316.4x in FY2025 indicates comfortable debt servicing capacity.
In FY 2025, Amrutanjan Health Care Limited reported an interest coverage ratio of 316.4x. Interest Coverage = EBIT / Interest Expense. Shows how many times operating profit covers interest payments. Above 5x is comfortable; below 1.5x signals potential difficulty servicing debt.
2-year trend showing financial leverage and capital structure
Amrutanjan Health Care Limited's debt-to-equity ratio of 0.01x in FY2025 reflects a conservative, low-leverage capital structure.
In FY 2025, Amrutanjan Health Care Limited reported a debt-to-equity ratio of 0.01. Debt-to-Equity = Total Debt / Total Equity. Below 1.0 is conservative; 1.0-2.0 is moderate; above 2.0 indicates higher financial risk. Capital-intensive industries naturally carry higher ratios.
2-year trend showing total debt with year-over-year changes
Amrutanjan Health Care Limited's debt increased 20.2% YoY in FY2025 — rising leverage demands close monitoring.
In FY 2025, Amrutanjan Health Care Limited's total debt increased by 20.2% year-over-year. Total Debt includes short-term debt, long-term loans, debentures, and capital leases. YoY changes (shown as percentages) reveal whether the company is leveraging up or deleveraging.
Year-over-year change in diluted shares outstanding
Amrutanjan Health Care Limited's diluted shares decreased 0.4% YoY in FY2025, indicating shareholder-friendly buybacks.
Over 2 years (FY2024–FY2025), diluted shares decreased 0.4% from 29.02M to 28.92M, reflecting long-term shareholder value creation.
In FY 2025, Amrutanjan Health Care Limited's diluted shares decreased by 0.4% year-over-year. Diluted Shares accounts for stock options, warrants, and convertibles. Positive YoY change means dilution (red); negative means buybacks (green). Consistent dilution above 5% annually is a red flag.
You're viewing 2 years of data. Upgrade to access 10 years of financial ratios, margins, and performance metrics.
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: FY 2025